A genotypic and phenotypic comparison of type III secretion profiles of Pseudomonas aeruginosa cystic fibrosis and bacteremia isolates

International Journal of Medical Microbiology

Volumn 297, Issue 4, 2007, Pages 227-234

  Wareham, David W ^a,b   Curtis, Michael A ^a  

^a Institute of Cell and Molecular Science   (United Kingdom)

^b BARTS HEALTH NHS TRUST   (United Kingdom)

Author keywords

Exoenzyme U; Pseudomonas aeruginosa; Type III secretion

Indexed keywords

BACTERIAL PROTEIN; BACTERIAL TOXIN; PROTEIN EXOU; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BACTEREMIA; BACTERIUM ISOLATE; BLOOD CULTURE; CYSTIC FIBROSIS; DISEASE ASSOCIATION; GENOTYPE; HUMAN; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; TYPE III SECRETION SYSTEM; WESTERN BLOTTING;

EID: 34249664460     PISSN: 14384221     EISSN: 16180607     Source Type: Journal    
DOI: 10.1016/j.ijmm.2007.02.004     Document Type: Article

References (30)

1. Ajayi T., Allmond A.R., Sawa T., and Wiener-Kronish J.P. Single-nucleotide-polymorphism mapping of the Pseudomonas aeruginosa type III secretion toxins for development of a diagnostic multiplex PCR system. J. Clin. Microbiol. 41 (2003) 3526-3531
2. Barbieri J.T., and Sun J. Pseudomonas aeruginosa ExoS and ExoT. Rev. Physiol. Biochem. Pharmacol. 152 (2004) 79-92
3. Berthelot P., Attree I., Plésiat P., Chabert J., de Bentzmann S., and Pozzetto B. Groupe d'Etudes des Septicémies à Pseudomonas aeruginosa. Genotypic and phenotypic analysis of type III secretion system in a cohort of Pseudomonas aeruginosa bacteremia isolates: evidence for a possible association between O serotypes and exo genes. J. Infect. Dis. 188 (2003) 512-518
4. Brun-Buisson C., Abrouk F., Legrand P., Huet Y., Larabi S., and Rapin M. Diagnosis of central venous catheter-related sepsis. critical level of quantitative tip cultures. Arch. Intern. Med. 147 (1997) 873-877
5. Dacheux D., Attree I., and Toussaint B. Expression of exsA in trans confers type III secretion system dependent cytotoxicity on non-cytotoxic Pseudomonas aeruginosa cystic fibrosis isolates. Infect. Immun. 69 (2001) 538-542
6. Goure J., Pastor A., Faudry E., Chabert J., Dessen A., and Attree I. The V antigen of Pseudomonas aeruginosa is required for assembly of the functional PopB/PopD translocation pore in host cell membranes. Infect. Immun. 72 (2004) 4741-4750
7. Faure K., Shimabukuro D., Ajayi T., Allmond L.R., Sawa T., and Wiener-Kronish J.P. O-antigen serotypes and type III secretory toxins in clinical isolates of Pseudomonas aeruginosa. J. Clin. Microbiol. 41 (2003) 2158-2160
8. Fauvarque M.O., Bergeret E., Chabert J., Dacheux D., Satre M., and Attree I. Role and activation of type III system in Pseudomonas aeruginosa induced Drosophila killing. Microb. Pathog. 32 (2002) 287-295
9. Feltman H., Shulert G., Khan S., Jain M., Peterson L., and Hauser A.R. Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa. Microbiology 147 (2001) 2659-2669
10. Filopon D., Merieau A., Bernot G., Comet J.P., Leberre R., Guery B., Polack B., and Guespin-Michel J. Epigenetic acquisition of inducibility of type III cytotoxicity in P. aeruginosa. BMC Bioinformatics 30 (2006) 272
11. Ha U., and Jin S. Growth phase-dependent invasion of Pseudomonas aeruginosa and its survival within HeLa cells. Infect. Immun. 69 (2001) 4398-4406
12. Hauser A.R., Cobb E., Bodi M., Mariscal D., Valles J., Engel J.N., and Rello J. Type III protein secretion is associated with poor clinical outcomes in patients with ventilator associated pneumonia caused by Pseudomonas aeruginosa. Crit. Care Med. 30 (2002) 521-528
13. Jain M., Ramirez D., Seshadri Cullina J.F., Powers C.A., Schulert G.S., Bar-Meir M., Sullivan C.L., McColley S.A., and Hauser A.R. Type III secretion phenotypes of Pseudomonas aeruginosa strains change during infection of individuals with cystic fibrosis. J. Clin. Microbiol. 42 (2004) 5229-5237
14. Li L., Ledizet M., Kar K., Koski R.A., and Kazmierczak B.I. An indirect enzyme-linked immunosorbent assay for rapid and quantitative assessment of type III virulence phenotypes of Pseudomonas aeruginosa isolates. Ann. Clin. Microbiol. Antimicrob. 4 (2005) 22
15. Lyczak J.B., Cannon C.L., and Pier G.B. Establishment of Pseudomonas aeruginosa infection: lessons from a versatile opportunist. Microbes Infect. 2 (2000) 1051-1060
16. McGuffie E.M., Fraylick J.E., Hazen-Martin D.J., Vincent T.S., and Olson J.C. Differential sensitivity of human epithelial cells to Pseudomonas aeruginosa exoenzyme S. Infect. Immun. 67 (1999) 3494-3503
17. Mundy R., Jenkins C., Yu J., Smith H., and Frankel G. Distrubution of espI among clinical enterohaemorrhagic and enteropathogenic E. coli isolates. J. Med. Microbiol. 53 (2004) 1145-1149
18. Nalca Y., Jansch L., Bredenbruch F., Geffers R., Buer J., and Haussler S. Quorum-sensing antagonistic activities of azithromycin in Pseudomonas aeruginosa PAO1: a global approach. Antimicrob. Agents Chemother. 50 (2006) 1680-1688
19. Pukatzki S., Kessin R.H., and Mekalanos J.J. The human pathogen Pseudomonas aeruginosa utilizes conserved virulence pathways to infect the social amoeba Dictyostelium discoideum. Proc. Natl. Acad. Sci. USA 99 (2002) 3159-3164
20. Renders N., Römling U., Verbrugh H., and van Belkum A. Comparative typing of Pseudomonas aeruginosa by random amplification of polymorphic DNA or pulsed-field gel electrophoresis of DNA macrorestriction fragments. J. Clin. Microbiol. 34 (1996) 3190-3195
21. Roy-Burman A., Savel R.H., Racine S., Swanson B.L., Revadigar N.S., Fujimoto J., Sawa T., Frank D.W., and Wiener-Kronish J.P. Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections. J. Infect. Dis. 183 (2001) 1767-1774
22. Sato H., and Frank D.W. ExoU is a potent intracellular phospholipase. Mol. Microbiol. 53 (2004) 1279-1290
23. Sawa T., Yahr T.L., Ohara M., Kurahashi K., Gropper M.A., Wiener-Kronish J.P., and Frank D.W. Active and passive immunisation with the Pseudomonas V antigen protects against type III intoxication and lung injury. Nat. Med. 5 (1999) 392-398
24. Schulert G.S., Feltman H., Rabin S.P., Martin C.G., Battle S.E., Rello J., and Hauser A.R. Secretion of the toxin ExoU is a marker for highly virulent Pseudomonas aeruginosa isolates obtained from patients with hospital acquired pneumonia. J. Infect. Dis. 188 (2003) 1695-1706
25. Spilker T., Coenye T., Vandamme P., and LiPuma J.J. PCR-based assay for differentiation of Pseudomonas aeruginosa from other Pseudomonas species recovered from cystic fibrosis patients. J. Clin. Microbiol. 42 (2004) 2074-2079
26. Stover C.K., Pham X.Q., Erwin A.L., Mizoguchi S.D., Warrener P., Hickey M.J., Brinkman F.S., Hufnagle W.O., Kowalik D.J., Lagrou M., Garber R.L., Goltry L., Tolentino E., Westbrock-Wadman S., Yuan Y., Brody L.L., Coulter S.N., Folger K.R., Kas A., Larbig K., Lim R., Smith K., Spencer D., Wong G.K., Wu Z., Paulsen I.T., Reizer J., Saier M.H., Hancock R.E., Lory S., and Olson M.V. Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen. Nature 406 (2000) 959-964
27. Tan M., Rahme L.G., Sternberg J.A., Tompkins R.G., and Ausubel F.M. Pseudomonas aeruginosa killing of Caenorhabditis elegans used to identify P. aeruginosa virulence factors. Proc. Natl. Acad. Sci. USA 96 (1999) 2408-2413
28. Vallis A.J., Finck-Barbancon V., Yahr T.L., and Frank D.W. Biological effects of Pseudomonas aeruginosa type III-secreted proteins on CHO cells. Infect. Immun. 67 (1999) 2040-2044
29. Wareham D.W., Papakonstatantinopoulou A., and Curtis M.A. The Pseudomonas aeruginosa PA14 type III secretion system is expressed but not essential to virulence in the Caenorhabditis elegans - P. aeruginosa pathogenicity model. FEMS Microbiol. Lett. 15 (2005) 209-216
30. Winstanley C., Kaye S.B., Neal T.J., Chilton H.J., Miksch S., Hart C.A., and Collab: and the Microbiology Ophthalmic Group. Genetic and phenotypic characteristics of Pseudomonas aeruginosa isolates associated with ulcerative keratitis. J. Med. Microbiol. 54 (2005) 519-526